The Wegovy injection pen has a needle already built-in to the device, while the Ozempic pen comes with needles to be attached
Multi-indication label expansion: Semaglutide approved across obesity, cardiovascular risk reduction, MASH, and sleep apnea creates a total addressable patient population of approximately 640 million globally nearly four times the obesity-only base adding new prescriber populations including cardiologists, hepatologists, and sleep medicine specialists
Whalen for administrative assistance
If anything becomes worse rather than better after 48 to 72 hours, call the clinician who gave you the shot
Phase 2 trials demonstrated 24.2% average weight loss at 48 weeks, with the 12mg dose producing up to 27.3% reduction in some participants
Abosi, O., Lopes, S., Schmitz, S